期刊文献+

JSRV-Env诱导转染NIH 3T3细胞后对VEGF和EGFR因子表达的影响

JSRV-Env-induced transfected NIH 3T3 and its impact on the expression of VEGF and EGFR
原文传递
导出
摘要 通过探索JSRV Env真核表达质粒诱导转染小鼠NIH 3T3(小鼠成纤维细胞)后对血管内皮生长因子(VEGF)和表皮生长因子受体(EGFR)表达的影响,进一步探讨其变化与绵羊肺腺瘤病(OPA)肿瘤发生的关联性。首先体外培养NIH 3T3细胞,设立转染pEGFP-C1-env、pEGFP-C1及未转染细胞组。本研究采用实时荧光定量PCR方法检测VEGF和EGFR mRNA水平上的表达;ELISA方法检测两细胞因子在不同处理的NIH 3T3细胞培养上清中蛋白的表达。结果显示,相比pEGFP-C1和未转染细胞组,转染pEGFP-C1-env细胞组中VEGF和EGFR mRNA的表达量均显著升高(P<0.05);且在该处理组的细胞培养上清中检测到VEGF和EGFR蛋白浓度呈明显上升趋势,差异均有统计学意义(P<0.05)。转染pEGFP-C1细胞组相比未转染细胞组VEGF和EGFR mRNA和蛋白表达量均差异不明显(P>0.05)。结果表明,JSRV Env在诱导转染小鼠NIH 3T3细胞转化过程中,通过qPCR和ELISA的检测结果均可得知VEGF和EGFR表达量均升高,由两者的过表达变化推测VEGF和EGFR在OPA肿瘤发生过程中可能起关键作用,同时为OPA针对两者进行的基因靶向治疗方法提供理论基础。 By observing JSRV Env eukaryotic expression plasmid transfected mouse NIH 3T3 (mouse fibroblast cell line) on influence of vascular endothelial growth factor (VEGF)and epider- mal growth factor receptor (EGFR) expression to further explore a relationghip between their changes and sheep pulmonary adenomatosis (OPA) association tumorigenesis. First in vitro cul- tured NIH3T3 cell to establish transfected pEGFP-CI-env, pEGFP-C1 and non-transfected cells. Then used real-time quantitative PCR method to detect the expression of VEGF and EGFR mRNA level and ELISA method to detect the expression of two cell factors in NIH 3T3 cell culture super- natant with different treatments. Compared with pEGFP-C1 and non-transfected cells,VEGF and EGFR mRNA expression in transfected with pEGFP-CI-env cell group was significantly increased (P〈0.05) ,and the VEGF and EGFR protein concentration in the cell culture supernatant was sig- nificantly increased(P〈0.05). Compared to non-transfected cells group VEGF and EGFR mRNA and protein expression levels had no significant difference in cells transfected with pEGFP-C1 group (P〉0.0;). In transfected NIH 3T3 cell transformation process in mice induced by JSRV Env VEGF and EGFR expression levels were increased , speculating that it may play a key role in OPA tumor. It provide a theoretical basis for gene therapy targeting based on OPA.
出处 《中国兽医学报》 CAS CSCD 北大核心 2017年第5期898-904,共7页 Chinese Journal of Veterinary Science
关键词 JSRV Env真核表达质粒 NIH 3T3细胞 VEGF因子 EGFR因子 JSRV-Env eukaryotic expression vector NIH 3T3 cell VEGF factor: EGFR factor
  • 相关文献

参考文献7

二级参考文献57

  • 1李军,洪梅,潘铁成.Clinical Significance of VEGF-C and VEGFR-3 Expression in Non-small Cell Lung Cancer[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2006,26(5):587-590. 被引量:7
  • 2Ling M T,Wang X,Zhang X,et al.The multiple roles of Id-1 in cancer progression[J].Differentiation,2006,74(9-10):481-7.
  • 3Wang Q,Tsao S W,Fu S,et al.Overexpression of Id-1 in gastric adenocarcinoma:implication for a novel diagnostic marker[J].Anticancer Res,2004,24(2B):881-6.
  • 4Kebebew E,Peng M,Treseler P A,et al.Id1 Gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells[J].J Clin Endocrinol Metab,2004,89(12):6105-11.
  • 5Jang K S,Han H X,Paik S S,et al.Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer[J].Cancer Letters,2006,244(2):203-10.
  • 6Zhao Z R,Zhang Z Y,Zhang H,et al.Overexpression of Id-1 protein is a marker in colorectal cancer progression[J].Oncol Rep,2008,19(2):419-24.
  • 7Xu B,Sun Y,Tang G,et al.Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor[J].Cancer Lett,2009,278(2):220-9.
  • 8Maw M K,Fujimoto J,Tamaya T.Expression of the inhibitor of DNA-binding(ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers[J].Br J Cancer,2008,99(10):1557-63.
  • 9Takai N,Miyazaki T,Fujisawa K,et al.Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma[J].Cancer Lett,2001,165(2):185-93.
  • 10Lynch T J,Bell D W,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J].N Engl J Med,2004,350(21):2129-39.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部